NCT04068896 2025-05-29
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
NGM Biopharmaceuticals, Inc
Phase 1/2 Completed
NGM Biopharmaceuticals, Inc
Seagen Inc.
Celgene
Celgene
Celgene
Celgene
Genta Incorporated